{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:46:49Z","timestamp":1787503609837,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["HEK293"],"award-info":[{"award-number":["HEK293"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD102786"],"award-info":[{"award-number":["R01HD102786"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.dmd.2025.100046","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T18:57:34Z","timestamp":1738609054000},"page":"100046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of selective substrates and inhibitors of the major human renal uptake transporters"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9541-3199","authenticated-orcid":false,"given":"Yik Pui","family":"Tsang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acilegna G.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-8455","authenticated-orcid":false,"given":"Jashvant D.","family":"Unadkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2025.100046_bib2","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1124\/dmd.109.028654","article-title":"Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs","volume":"37","author":"Ahlin","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100046_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10637-018-0644-3","article-title":"The monocarboxylate transporter inhibitor quercetin induces intracellular acidification in a mouse model of glioblastoma multiforme: in-vivo detection using magnetic resonance imaging","volume":"37","author":"Albatany","year":"2019","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.dmd.2025.100046_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejps.2017.02.011","article-title":"Identification of novel MRP3 inhibitors based on computational models and validation using an in\u00a0vitro membrane vesicle assay","volume":"103","author":"Ali","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.dmd.2025.100046_bib5","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1074\/jbc.M800737200","article-title":"Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13)","volume":"283","author":"Bahn","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dmd.2025.100046_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152535","article-title":"Freshly isolated primary human proximal tubule cells as an in\u00a0vitro model for the detection of renal tubular toxicity","volume":"442","author":"Bajaj","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.dmd.2025.100046_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s002280100364","article-title":"Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers","volume":"57","author":"Benedetti","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1440010","article-title":"The effect of pregnancy-related hormones on hepatic transporters: studies with premenopausal human hepatocytes","volume":"15","author":"Benzi","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/jpet.105.084301","article-title":"Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6)","volume":"314","author":"Bleasby","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100046_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00424-008-0526-1","article-title":"Ascorbic acid participates in a general mechanism for concerted glucose transport inhibition and lactate transport stimulation","volume":"457","author":"Castro","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.dmd.2025.100046_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/17425255.2013.741589","article-title":"Species differences in drug transporters and implications for translating preclinical findings to humans","volume":"9","author":"Chu","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.dmd.2025.100046_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3565(25)30045-5","article-title":"Renal mechanisms for the excretion of nicotinic acid","volume":"192","author":"Corr","year":"1975","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100046_bib15","first-page":"1615","article-title":"Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans","volume":"138","author":"Egert","year":"2008","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.dmd.2025.100046_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.trsl.2013.08.003","article-title":"Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4","volume":"162","author":"El-Sheikh","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.dmd.2025.100046_bib17","series-title":"VISTIDE\u00ae (cidofovir injection)","year":"2000"},{"key":"10.1016\/j.dmd.2025.100046_bib19","series-title":"NOVANTRONE\u00ae","year":"2010"},{"key":"10.1016\/j.dmd.2025.100046_bib20","series-title":"TENORMIN\u00ae (atenolol)","year":"2011"},{"key":"10.1016\/j.dmd.2025.100046_bib22","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/jphp.12574","article-title":"L503F variant of carnitine\/organic cation transporter 1 efficiently transports metformin and other biguanides","volume":"68","author":"Futatsugi","year":"2016","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bcp.2007.04.015","article-title":"Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations","volume":"74","author":"Grigat","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib24","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1073\/pnas.0408624102","article-title":"Discovery of the ergothioneine transporter","volume":"102","author":"Gr\u00fcndemann","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dmd.2025.100046_bib25","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/toxins2082055","article-title":"Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity","volume":"2","author":"Hagos","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.dmd.2025.100046_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/jpet.123.002019","article-title":"Dysregulation of human hepatic drug transporters by proinflammatory cytokines","volume":"391","author":"Hao","year":"2024","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100046_bib27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejpb.2012.07.020","article-title":"Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood\u2013brain barrier penetration models","volume":"82","author":"Hellinger","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.dmd.2025.100046_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00338-y","article-title":"Bridging the gap between in silico and in\u00a0vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system","volume":"11","author":"Imaoka","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmd.2025.100046_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.106.028233","article-title":"Functional involvement of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir","volume":"71","author":"Imaoka","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2169","article-title":"A\u00a0single-cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.dmd.2025.100046_bib31","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s11095-010-0076-z","article-title":"Gene knockout and metabolome analysis of carnitine\/organic cation transporter OCTN1","volume":"27","author":"Kato","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.dmd.2025.100046_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejpb.2010.03.008","article-title":"Development of a fluorescence-based assay for drug interactions with human multidrug resistance related protein (MRP2; ABCC2) in MDCKII-MRP2 membrane vesicles","volume":"75","author":"Lechner","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.dmd.2025.100046_bib33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF01046701","article-title":"Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration","volume":"34","author":"Legg","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood.V96.1.377","article-title":"Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia","volume":"96","author":"Maloum","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.dmd.2025.100046_bib35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1055\/s-0034-1382760","article-title":"Evaluation of in\u00a0vitro absorption, distribution, metabolism, and excretion (ADME) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline","volume":"80","author":"Manda","year":"2014","journal-title":"Planta Med"},{"key":"10.1016\/j.dmd.2025.100046_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113829","article-title":"Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7)","volume":"174","author":"Mathialagan","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib37","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/00498254.2017.1384595","article-title":"In\u00a0vitro studies with two human organic anion transporters: OAT2 and OAT7","volume":"48","author":"Mathialagan","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmd.2025.100046_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/dmd.116.074294","article-title":"Quantitative prediction of human renal clearance and drug-drug interactions of organic anion transporter substrates using in\u00a0vitro transport data: a relative activity factor approach","volume":"45","author":"Mathialagan","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100046_bib39","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1073\/pnas.0304987101","article-title":"Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney","volume":"101","author":"Mikkaichi","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.dmd.2025.100046_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.aca.2006.03.007","article-title":"Identification of P-glycoprotein substrates using open tubular chromatography on an immobilized P-glycoprotein column: Comparison of chromatographic results with Caco-2 permeability","volume":"578","author":"Moaddel","year":"2006","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.dmd.2025.100046_bib41","first-page":"307","article-title":"New insight into organic anion transporters from the perspective of potentially important interactions and drugs toxicity","volume":"69","author":"Mor","year":"2018","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.dmd.2025.100046_bib43","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/00498250601188808","article-title":"Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans","volume":"37","author":"Nakagomi-Hagihara","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmd.2025.100046_bib44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"Nishimura","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100046_bib45","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.xphs.2017.03.026","article-title":"Cellular uptake of levocetirizine by organic anion transporter 4","volume":"106","author":"Noguchi","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.dmd.2025.100046_bib46","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/ijms23020914","article-title":"OCTN1: a widely studied but still enigmatic organic cation transporter linked to human pathology and drug interactions","volume":"23","author":"Pochini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dmd.2025.100046_bib47","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/ijms21031091","article-title":"Effect of cholesterol on the organic cation transporter OCTN1 (SLC22A4)","volume":"21","author":"Pochini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dmd.2025.100046_bib48","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1158\/1078-0432.CCR-04-1725","article-title":"Cyclosporin A is a broad-spectrum multidrug resistance modulator","volume":"11","author":"Qadir","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.dmd.2025.100046_bib49","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib50","series-title":"Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications","author":"Rowland","year":"2011"},{"key":"10.1016\/j.dmd.2025.100046_bib51","doi-asserted-by":"crossref","first-page":"14578","DOI":"10.1021\/acs.jmedchem.2c01079","article-title":"Identification of organic anion transporter 2 inhibitors: screening, structure-based analysis, and clinical drug interaction risk assessment","volume":"65","author":"Ryu","year":"2022","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.dmd.2025.100046_bib52","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s11095-017-2184-5","article-title":"Investigation of glycochenodeoxycholate sulfate and chenodeoxycholate glucuronide as surrogate endogenous probes for drug interaction studies of OATP1B1 and OATP1B3 in healthy Japanese volunteers","volume":"34","author":"Takehara","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.dmd.2025.100046_bib53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bcp.2007.04.010","article-title":"Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions\/H(+)-organic cation antiporters","volume":"74","author":"Tanihara","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib54","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/FTD.0000000000000353","article-title":"Brincidofovir is not a substrate for the human organic anion transporter 1: a mechanistic explanation for the lack of nephrotoxicity observed in clinical studies","volume":"38","author":"Tippin","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.dmd.2025.100046_bib55","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1210\/en.2015-1130","article-title":"Role of OAT4 in uptake of estriol precursor 16\u03b1-hydroxydehydroepiandrosterone sulfate into human placental syncytiotrophoblasts from fetus","volume":"156","author":"Tomi","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.dmd.2025.100046_bib56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/pharmaceutics16020285","article-title":"Dysregulation of the mRNA expression of human renal drug transporters by proinflammatory cytokines in primary human proximal tubular epithelial cells","volume":"16","author":"Tsang","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.dmd.2025.100046_bib57","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/dmd.118.080440","article-title":"Substrate selectivity check of the ergothioneine transporter","volume":"46","author":"Tschirka","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100046_bib58","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1124\/dmd.116.071472","article-title":"Investigation of endogenous compounds applicable to drug\u2013drug interaction studies involving the renal organic anion transporters, OAT1 and OAT3, in humans","volume":"44","author":"Tsuruya","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100046_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.dmd.2025.100046_bib60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","article-title":"Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)","volume":"24","author":"Uwai","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.dmd.2025.100046_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bcp.2007.03.024","article-title":"Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3","volume":"74","author":"Uwai","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmd.2025.100046_bib62","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1124\/dmd.117.077248","article-title":"Colistin is substrate of the carnitine\/organic cation transporter 2 (OCTN2, SLC22A5)","volume":"45","author":"Visentin","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100046_bib63","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.kint.2016.06.011","article-title":"Development of a microphysiological model of human kidney proximal tubule function","volume":"90","author":"Weber","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.dmd.2025.100046_bib64","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s40262-021-01004-2","article-title":"Clinical investigation on endogenous biomarkers to predict strong OAT-mediated drug\u2013drug interactions","volume":"60","author":"Willemin","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100046_bib65","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1124\/jpet.107.125831","article-title":"The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin","volume":"322","author":"Windass","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100046_bib66","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1021\/jm301302s","article-title":"Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling","volume":"56","author":"Wittwer","year":"2013","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.dmd.2025.100046_bib67","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/jpet.116.236158","article-title":"Impact of substrate-dependent inhibition on renal organic cation transporters hOCT2 and hMATE1\/2-K-mediated drug transport and intracellular accumulation","volume":"359","author":"Yin","year":"2016","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100046_bib68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.apsb.2016.07.013","article-title":"Renal drug transporters and their significance in drug\u2013drug interactions","volume":"6","author":"Yin","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.dmd.2025.100046_bib69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3892\/or.2015.4343","article-title":"Multidrug resistance-associated protein 4 is a determinant of arsenite resistance","volume":"35","author":"Yuan","year":"2016","journal-title":"Oncol Rep"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625090555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625090555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:17:09Z","timestamp":1746101829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625090555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0090955625090555"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100046","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of selective substrates and inhibitors of the major human renal uptake transporters","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100046"}}